TRIL
Vanguard Group’s Trillium Therapeutics Inc. TRIL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-554,749
| Closed | -$9.74M | – | 4706 |
|
|
2021
Q3 | $9.74M | Buy |
554,749
+155,450
| +39% | +$2.73M | ﹤0.01% | 3259 |
|
|
2021
Q2 | $3.87M | Buy |
399,299
+327,966
| +460% | +$3.18M | ﹤0.01% | 3722 |
|
|
2021
Q1 | $766K | Buy |
71,333
+3,866
| +6% | +$41.5K | ﹤0.01% | 4060 |
|
|
2020
Q4 | $993K | Buy |
+67,467
| New | +$993K | ﹤0.01% | 3828 |
|